SEC FORM
4
SEC Form 4
| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
|
| OMB APPROVAL |
| OMB Number: |
3235-0287 |
| Estimated average burden |
| hours per response: |
0.5 |
|
|
 |
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
CHARLES RIVER LABORATORIES INTERNATIONAL INC
[ CRL ]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
Director |
|
10% Owner |
| X |
Officer (give title below) |
|
Other (specify below) |
| Senior Vice President |
|
3. Date of Earliest Transaction
(Month/Day/Year)
04/03/2006
|
4. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
| X |
Form filed by One Reporting Person |
|
Form filed by More than One Reporting Person |
|
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
|---|
| 1. Title of Security (Instr.
3)
|
2. Transaction Date
(Month/Day/Year) |
2A. Deemed Execution Date, if any
(Month/Day/Year) |
3. Transaction Code (Instr.
8)
|
4. Securities Acquired (A) or Disposed Of (D) (Instr.
3, 4 and 5)
|
5.
Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)
|
7. Nature of Indirect Beneficial Ownership (Instr.
4)
|
| Code |
V |
Amount |
(A) or (D) |
Price |
| Restricted Common Stock |
04/03/2006 |
|
A |
|
8,850
|
A |
$0.00
|
8,850 |
D |
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
|
|---|
| 1. Title of Derivative Security (Instr.
3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Transaction Date
(Month/Day/Year) |
3A. Deemed Execution Date, if any
(Month/Day/Year) |
4. Transaction Code (Instr.
8)
|
5.
Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
3, 4 and 5)
|
6. Date Exercisable and Expiration Date
(Month/Day/Year) |
7. Title and Amount of Securities Underlying Derivative Security (Instr.
3 and 4)
|
8. Price of Derivative Security (Instr.
5)
|
9.
Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
4)
|
10. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)
|
11. Nature of Indirect Beneficial Ownership (Instr.
4)
|
| Code |
V |
(A) |
(D) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
| Stock Options (Right to Buy) |
$49.39
|
04/03/2006 |
|
A |
|
21,650 |
|
|
04/03/2016 |
Common Stock |
21,650 |
$0.00
|
21,650 |
D |
|
| Explanation of Responses: |
|
|
| Remarks: |
|
|
/s/Nicholas Ventresca |
04/05/2006 |
|
** Signature of Reporting Person |
Date |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
| * If the form is filed by more than one reporting person,
see
Instruction
4
(b)(v). |
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
POWER OF ATTORNEY SECTION 16 FILINGS
Know all by these presents,
that
the undersigned hereby constitutes and appoints Joanne (Jody) P.
Acford and
Matthew L. Daniel as the undersigned's true and lawful
attorneys in fact
to:
(1) prepare, execute in the undersigned's
name and on the
undersigned's behalf, and submit to the U.S. Securities
and Exchange
Commission (the "SEC") a Form ID, including amendments
thereto, and any
other documents necessary or appropriate to obtain codes
and passwords
enabling the undersigned to make electronic filings with
the SEC of reports
required by Section 16(a) of the Securities Exchange
Act of 1934 or any
rule or regulation of the SEC;
(2) execute for
and on behalf of the
undersigned, in the undersigned's capacity as an
officer and/or director of
Charles River Laboratories International, Inc.
(the "Company"), Forms 3, 4,
and 5 in accordance with Section 16(a) of
the Securities Exchange Act of
1934 and the rules thereunder, and any
other forms or reports the
undersigned may be required to file in
connection with the undersigned's
ownership, acquisition, or disposition
of securities of the Company;
(3) do and perform any and all acts
for and on behalf of the undersigned
which may be necessary or desirable
to complete and execute any such Form
3, 4, or 5, complete and execute
any amendment or amendments thereto, and
timely file such form with the
United States Securities and Exchange
Commission and any stock exchange
or similar authority; and
(4) take
any other action of any type
whatsoever in connection with the foregoing
which, in the opinion of such
attorney in fact, may be of benefit to, in
the best interest of, or
legally required by, the undersigned, it being
understood that the
documents executed by such attorney in fact on behalf
of the undersigned
pursuant to this Power of Attorney shall be in such form
and shall
contain such terms and conditions as such attorney in fact may
approve in
such attorney in fact's discretion.
The undersigned hereby
grants
the attorney in fact full power and authority to do and perform any
and
every act and thing whatsoever requisite, necessary, or proper to be
done
in the exercise of any of the rights and powers herein granted, as
fully
to all intents and purposes as the undersigned might or could do if
personally present, with full power of substitution or revocation, hereby
ratifying and confirming all that such attorney in fact, or such attorney
in fact's substitute or substitutes, shall lawfully do or cause to be
done
by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorney in
fact,
in serving in such capacity at the request of the undersigned, is
not
assuming, nor is the Company assuming, any of the undersigned's
responsibilities to comply with Section 16 of the Securities Exchange Act
of 1934.
This Power of Attorney shall remain in full force and
effect
until the undersigned is no longer required to file Forms 3, 4,
and 5 with
respect to the undersigned's holdings of and transactions in
securities
issued by the Company, unless earlier revoked by the
undersigned in a
signed writing delivered to the foregoing attorneys in
fact.
IN
WITNESS WHEREOF, the undersigned has caused this Power
of Attorney to be
executed as of this 4th day of April, 2006.
/s/Nicholas
Ventresca
Signature
Nicholas Ventresca
Print Name
